-The Times of India Malnutrition kills more Indians than any specific disease. That’s hardly surprising since a weakened body is more prone to infections and responds less to medicine or treatment than a well-fed, healthy one. Widespread malnutrition has been termed a national shame and a top priority. Yet, the debate in governments is mostly about whether or not to give packaged food and whether deficiencies of vitamins and minerals should be...

-The Hindu Governments must be judged on the quality and extent of the public health care they provide The deaths of more than 70 children in one hospital in Gorakhpur and 49 in Farrukhabad, both in Uttar Pradesh recently, reflect the appalling state of public health in India. However, it needs to be remembered that India’s public health care sector has been ailing for decades. According to the latest Global Burden of...

-Scroll.in Terms of agreement give private players 30-year lease over parts of government district hospitals. Niti Aayog and the Union ministry for health and family welfare have proposed a model contract to increase the role of private hospitals in treating non-communicable diseases in urban India. The agreement, which has been been shared with states for their comments, allows private hospitals to bid for 30-year leases over parts of district hospital buildings...

-The Telegraph New Delhi: India's drug pricing rules allow companies to inflate the maximum retail prices of medicines, including life-saving drugs, costing patients thousands of additional rupees while offering slices of the profits to stockists, chemists, and hospitals. Quotations received by hospitals from drug companies' representatives offering discounts on maximum retail prices (MRPs) of medicines provide what some doctors and patients' rights advocates say is fresh evidence for excessive profiteering in India's...

-The Indian Express Responding to specific queries on the issue, Bhupendra Singh, NPPA chairman, told The Indian Express that “examination of hospital records is in process”. AFTER the National Pharmaceutical Pricing Authority (NPPA) in February ordered a cap on the prices of coronary stents and directed hospitals to issue separate bills specifying their cost, the drug pricing watchdog has started receiving consumer complaints against hospitals which are allegedly hiking the prices...